There’s every reason to slow AI development. But here’s why it probably won’t happen.
The risks of disaster are real. But who wants to give up those massive stock valuations? Source：MarketWatch
‘My total balance should be $20 million’: I invested $1.1 million in a crypto platform. Have I lost it all?
“I invested on the recommendation of an executive vice president of a major New York investment bank.” Source：MarketWatch
10-year Treasury yield briefly tops 5%, hitting its highest level since 2007 as bond-market selloff deepens
The benchmark 10year Treasury yield briefly touched the crucial 5% threshold on Monday, with oil prices marching higher, jitters about artificial intelligence…
Clarity Act odds surge on prediction markets, but crypto bill still faces long road
Kalshi and Polymarket bettors sharply raised the chances of U.S. crypto market structure legislation advancing, with Tuesday's Senate vote the next test.…
Don’t let perfect be the enemy of Clarity
On September 15, the Senate has the chance to show that it can address issues in a reasonable timeframe, rather than waiting for the next market failure to…
Couples with a big age gap need more money — they have to plan for two retirements
These are the biggest issues to consider when there’s more than a 10year age difference. Source：MarketWatch
Kaiko extends Series B funding round to $110 million with S&P Global, BNP Paribas
Financial rating giant S&P Global joined top traditional banks and exchange operators to fund Kaiko's expansion into continuous market data services…
Here’s how to prepare your portfolio for the Fed’s next interest-rate moves
History suggests the bull market in stocks will continue if the Fed raises interest rates this week, but there are things investors can do to take some…
HYPE price could suffer as Binance takes its revenue: Alice Liu
Token buybacks have pushed Hyperliquid to all time highs, but Alice Liu from CoinMarketCap warns that Binance poses a threat to the revenue stream it depends…
Novo drops ‘Nordisk’ in corporate refresh to take on Lilly in the weight-loss wars
The Danish drug giant behind Ozempic is competing with Eli Lilly in the market for weightloss drugs. Source：MarketWatch
Dogecoin ETFs struggled for buyers while rival XRP and Solana funds pulled in $3 billion
Bitwise's BWOW dogecoin ETF will close after 10 months, adding to weak demand across DOGE funds and raising a harder question for altcoin ETFs: What problem…
Oil over $100 has JPMorgan strategists warning stock-market investors against missing out on a sudden turnaround
Brent crude and West Texas Intermediate’s frontmonth contracts rose on Monday after Saudi Arabia closed its EastWest pipeline, citing damage cause by drone…